Vanderbilt Institute Of Chemical Biology

A new imaging probe developed by Vanderbilt investigators enhances tumor visibility and has broad applications in diagnosing and monitoring patients with cancer. Read More

Jennifer Doudna, Ph.D., recipient of a 2015 Breakthrough Prize in Life Sciences, will deliver the next Flexner Discovery Lecture on Thursday, Jan. 8. Read More

A new compound that activates potassium channels could be used to treat disorders of glucose homeostasis. Read More

Vanderbilt researchers have identified a new signaling system that anthrax bacteria uses to infect its host. Read More

The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development. Read More

Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center. Read More

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug. Read More

Osteomyelitis, a debilitating bone infection most frequently caused by Staphylococcus aureus (“staph”) bacteria, is particularly challenging to treat. Read More

The Vanderbilt Institute of Chemical Biology (VICB) celebrated its 10th anniversary Tuesday with a daylong research symposium. Read More

Scott Hultgren, Ph.D., an expert on the interactions between bacteria and human hosts, will deliver the next Flexner Discovery Lecture on Thursday, March 7. Read More

Top chemists from around the country will be on hand March 12 to celebrate the 10th anniversary of the Vanderbilt Institute of Chemical Biology (VICB), a brave experiment that helped jumpstart the University’s robust drug discovery initiative. Read More

It’s possible to cure Chagas disease – a deadly tropical infection transmitted by “kissing bugs” – in a mouse model. Read More

Understanding how the main receptor for light interacts with other signaling molecules may inform new pharmaceutical development. Read More

The molecular structure of a protein involved in Alzheimer’s disease – and the surprising discovery that it binds cholesterol – could lead to new therapeutics for the memory-robbing disease. Read More

Antioxidants may be a beneficial treatment for an inherited genetic disorder. Read More

The April program for My Health Chat will be the promising world of cancer drug discovery. Panelists will be Lawrence Marnett, director of the Vanderbilt Institute of Chemical Biology, and Stephen Fesik, director of drug discovery at Vanderbilt-Ingram Cancer Center. They will discuss… Read More

Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs. Read More

A new understanding of the biochemical pathway that builds our skin barrier could lead to treatments for skin diseases. Read More

Vanderbilt researchers are using a variety of approaches to hasten the beginning of the end of malaria. Read More

Caving expert John Hickman, who accompanies Bachmann on his underground expeditions, rappels down to the entrance of the Snail Shell Cave near Murfreesboro, Tenn Have you ever had the feeling that events beyond your control are working in your favor? That certainly seems to have been the case in the… Read More